Evidence map›Paper›PMID 38783715›Full record

ArticleJournal of burn care & research : official publication of the American Burn Association2025

Monocyte Anisocytosis Changes in Patients After Major Burn Injuries.

Saeed Nazemidashtarjandi, Sinan Muldur, Matthew D Supple, Colleen M Ryan, Lael M Yonker, Murat N Karabacak, Jeremy Goverman, Martin L Yarmush, Daniel Irimia

Abstract read
In one paragraph

Article in Journal of burn care & research : official publication of the American Burn Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Resolvin D2 restores monocyte anisocytosis and mediates a shift toward classical monocytes ex vivo in blood samples from patients after major burns.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Saeed NazemidashtarjandiDepartment of Surgery, Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0002-0355-7141
Sinan MuldurDepartment of Surgery, Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0003-3258-9086
Matthew D SuppleDepartment of Surgery, Sumner Redstone Burn Center, Massachusetts General Hospital, Boston, MA 02114, USA.
Colleen M RyanHarvard Medical School, Boston, MA 02114, USA.ORCID 0000-0002-6455-936X
Lael M YonkerHarvard Medical School, Boston, MA 02114, USA.ORCID 0000-0003-1711-8227
Murat N KarabacakDepartment of Surgery, Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0003-2761-5593
Jeremy GovermanHarvard Medical School, Boston, MA 02114, USA.
Martin L YarmushDepartment of Surgery, Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA 02129, USA.
Daniel IrimiaDepartment of Surgery, Center for Engineering in Medicine and Surgery, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0001-7347-2082

Funding

Neutrophil Decision Making in Confined Environments in Health and DiseaseR01GM092804 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI IRIMIA, DANIEL · 2010 to 2022
$4.3M
NIGMS NIH HHS R01 GM092804NIH HHS GM092804Shriners Hospitals for Children-Boston 85110-BOS-22
6 · The paper itself

Abstract

The recovery of patients after severe burns is a long and complex process. Genomic analysis of white blood cells from burn and trauma patients revealed excessive and prolonged innate immune activation in patients with complicated outcomes. However, translating this knowledge into practical biomarkers has not been possible yet. Although several biomarkers for monitoring burn patients have been proposed, their ability to accurately distinguish between inflammation stemming from initial tissue destruction, infections, and organ failure complications is limited. Here, we focused on monocytes, critical innate immune cells in the response to burn injured tissues. We measured the monocyte anisocytosis (quantified as monocyte distribution width (MDW), a recently emerged marker of sepsis) throughout the recovery of patients from the time of burn injury until the end of the hospital stay. We observed that MDW increases in patients during the first week after major burns. Among the patients with major burns who survive, MDW starts decreasing in the second week and normalizes by the end of the hospital stay. The duration of hospital stay appears to be proportional to how fast MDW decreases during the second week after the injury. We also found that MDW decreases significantly in most patients after excision and debridement surgeries but not after allo- and auto-graft surgeries. Moreover, high MDW values correlated with a higher rate of positive microbiology blood culture samples and respiratory infections. These findings underscore the importance of monitoring MDW as a potential biomarker for the risk of complications during burn patient recovery.

Indexed as

BurnsLeukocytosisMonocytesAdultBiomarkersFemaleHumansLength of StayMaleMiddle AgedBiomarkersbiomarkerburn injurymonocyte anisocytosis

Identifiers

PMID38783715
PMCPMC11761730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.